CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $104,000 | -36.2% | 87,500 | -16.8% | 0.00% | – |
| Q2 2021 | $163,000 | -56.3% | 105,200 | -32.3% | 0.00% | – |
| Q1 2021 | $373,000 | +12.0% | 155,288 | +37.5% | 0.00% | – |
| Q4 2020 | $333,000 | +197.3% | 112,917 | +53.7% | 0.00% | – |
| Q3 2020 | $112,000 | -39.1% | 73,477 | 0.0% | 0.00% | – |
| Q2 2020 | $184,000 | +23.5% | 73,477 | +0.7% | 0.00% | – |
| Q1 2020 | $149,000 | -33.8% | 72,976 | 0.0% | 0.00% | – |
| Q4 2019 | $225,000 | -5.1% | 72,976 | +2.8% | 0.00% | – |
| Q3 2019 | $237,000 | +4.9% | 70,978 | +0.4% | 0.00% | – |
| Q2 2019 | $226,000 | +11.3% | 70,674 | +0.1% | 0.00% | – |
| Q1 2019 | $203,000 | -28.3% | 70,574 | +0.1% | 0.00% | – |
| Q4 2018 | $283,000 | +20.9% | 70,474 | +40.9% | 0.00% | – |
| Q3 2018 | $234,000 | -42.8% | 50,012 | +0.6% | 0.00% | – |
| Q2 2018 | $409,000 | +98.5% | 49,733 | +0.7% | 0.00% | – |
| Q1 2018 | $206,000 | +25.6% | 49,400 | -2.0% | 0.00% | – |
| Q4 2017 | $164,000 | – | 50,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
| Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
| Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
| IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
| Perceptive Advisors | 43,682 | $204,000 | 0.01% |
| ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |